Nov 6, 2024 - Nov 6, 2024 8:00 to 9:30 pm ET (5:00 pm PT, 7:00 pm CT, 9:00 pm AT) Canada Wide Peer Connect Event Ready to connect with those who understand the challenges of Crohn’s disease, ulcerative colitis, and other forms of inflammatory bowel disease (IBD)? Join our upcoming Peer Connect ... Read MoreEn savoir plus LocationEmplacement • Virtual CategoryCatégorie • Peer supportSoutien entre pairs
Nov 7, 2024 - Nov 7, 2024 6:30 PM Michael Assaraf Pharmacy presents the Montreal Gala for Crohn's and Colitis Canada Crohn’s and Colitis Canada invites you to join us for an unforgettable night of food, music, casino games, entertainment and networking in the historic Marché Bonsecours. Please join us in ... Read MoreEn savoir plus LocationEmplacement • 310 St. Paul E., Montréal, QC H2Y 1J3 Montreal CategoryCatégorie • FundraisingLevée de fonds
Nov 8, 2024 - Nov 9, 2024 Conult registration for times Meeting of the Minds Join us for the definitive educational event of the year in Inflammatory Bowel Disease for healthcare! Who should attend: Physicians, Scientists, Researchers, Nurses, Postgraduate Residents & ... Read MoreEn savoir plus LocationEmplacement • Westin Harbour Castle 1 Harbour Square Toronto, Ontario Canada M5J 1A6 Toronto CategoryCatégorie • EducationÉducation
Nov 26, 2024 - Nov 26, 2024 7 00 PM - 8 30 PM ET From Childhood to the Elderly: Navigating IBD Care From Childhood to the Elderly: Navigating IBD CareDate: November 26, 2024 Time: 7:00 - 8:30 p.m. ET Have you ever wondered how Crohn’s disease and ulcerative colitis impact ... Read MoreEn savoir plus LocationEmplacement • ZOOM (Virtual) CategoryCatégorie • EducationÉducation
Nov 8, 2022 The Canadian Inflammatory Bowel Disease Research Consortium awards first $1M Pioneer Grant from Takeda Canada Learn moreEn savoir plus
Nov 7, 2022 Crohn’s and Colitis Canada and Pfizer Canada Announce 2022 Women in IBD Award Recipients Learn moreEn savoir plus
Nov 1, 2022 November is Crohn’s & Colitis Awareness Month, and We Need Your Help Learn moreEn savoir plus
Oct 20, 2022 Health Canada has approved SKYRIZI® (risankizumab) an intravenous and subcutaneous medication treatment for adults with moderately to severely active Crohn's Disease Learn moreEn savoir plus
Oct 13, 2022 Send an eCard to Friends or Family Members in Support of Crohn's and Colitis Canada Learn moreEn savoir plus